Stomach-shrinking procedure may help control blood sugar and delay insulin in type 2 diabetes
NCT ID NCT07639684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether a weight-loss procedure called endoscopic sleeve gastroplasty (ESG) can improve blood sugar control and reduce the need for insulin in adults with obesity and type 2 diabetes. Participants have poorly controlled diabetes despite taking standard medications, including GLP-1 drugs. The study will measure changes in blood sugar levels and track serious side effects over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Endoscopic Sleeve Gastroplasty (ESG) with OverStitch Endoscopic Suturing System
What this could lead to
If it works, this could offer a way to improve blood sugar control and reduce or delay the need for insulin in people with obesity and type 2 diabetes.
What could go wrong
This is a small, early-stage trial with no control group, so results may not apply broadly. The procedure carries risks of serious side effects, and weight loss may not be enough to meaningfully change diabetes outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2D) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••